Page 50 - Special Issue: Healthy Baby

that address PMS, skin problems, endometriosis, Obstet Gyn, 1990;163(1) pt. 2:274-281.
vaginal infections, pregnancy and menopause. 11. Researchers, including Dr. Merethe Kumle of Community Medicine in
Tromso, Norway, followed 103,027 women between the ages of 30 to
Weed, Susun, Wise Woman Herbal for the 49 from 1991-1999, and reported their findings at the Third European
Breast Cancer Conference, 2002.
Childbearing Year, Ash Tree Publishing, 1985. 12. Caruso S, C Grillo and others. A Prospective Study Evidencing Rhi-
A classic. nomanumetric and Olfactometric Outcomes in Women Taking Oral
Contraceptives. Human Reproduction, 16 Oct. 2001;11:2288-94.
Weed, Susun, The New Menopausal Years the 13. Diamanti-Kandarakis, Evanthia and others. A modern medical
Wise Woman Way: Alternative Approaches for quandry: Polycyctic ovary syndrome, insulin resistance and oral
Women 30 - 90, Ash Tree Publishing, 2002. cnotraceptive pills. Journal of Clinical Endocrinology & Metabolism
Presents remedies for menstrual cramps, thyroid 2003;88(5):1927-1932.
problems, vaginal dryness, fertility after forty 14. Scholes, D, AZ LaCroix and others. Bone mineral density in women
using depot medroxyprogesterone acetate for contraception. Obstet
and more. Gynecol 1999;93(2):233-38.; Cromer, BA, JM Blair and others. A
prospective comparison of bone density in adolescent girls receiving
REFERENCES depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel
1. Marx, Theresa, MD and A Mehta, MD. (Norplant), or oral contraceptives. J Pediatr 1996;129(5):671-76.
Polycystic ovary syndrome: Pathogenesis 15. Skegg, DCG, EA Noonan and others. Depot medroxprogesterone
and treatment over the short and long term. acetate and breast cancer: A pooled analysis of the World Health Or-
Cleveland Clinic Journal of Medicine, Janu- ganization and New Zealand studies. JAMA, 1995 Mar 8:10:799-804.
ary, 2003;70:1, 31-45. 16. Whittemore A and others. Characteristics relating to ovarian cancer risk;
2. Turiel, Judith Steinberg, Beyond Second collaborative analysis of twelve U.S. case-controlled studies. American
Opinions: Making Choices About Fertility Journal of Epidemiology 136(10):1175-1220.
Treatment, University of California Press, 17. Rossing, Daling and Weiss. Ovarian tumors in a cohort of infertile
1998, p.18. women. New England Journal of Medicine, 1994;331:(12)771-6.
3. Barr Laboratories SEASONALE Conference 18. Anteby IE and others. Ocular manifestations in children born after in
Call, Sept. 8, 2003, transcript 090803ak.772. vitro fertilization. Arch Opthalmol, Oct. 2001;119(10):1525-9. Ocular
4. Billings, Evelyn, MD, The Billings Method, anomalies (eye problems) were frequently observed in this cohort of
Penguin Books Australia, 2000, p. 164-165. offspring born after in vitro fertilization.
5. Hatcher, RA and others. Hormonal Overview. 19. Hansen M and others. The risk of major birth defects after intracyto-
Contraceptive Technology, 14th Ed, Irving- plasmic sperm injection and in vitro fertilization. N Engl J Med, 2002
ton, 191-192. Oct 31;347(18):1449-51. Infants conceived with use of intracytoplasmic
6. Larimore, MD, Walter, and Joseph Stanford, sperm injection or in vitro fertilization have twice as high a risk of a
MD, MSPH. Postfertilization Effects of major birth defect as naturally conceived infants.
Oral Contraceptives and Their Relationship 20. Koivurova S and others. Neonatal outcome and congenital malforma-
to Informed Consent. Arch Fam Med, Feb tions in children born after in vitro fertilization. Hum Reprod, May
2000;9(23). 2002;17(5):1391-8. Neonatal outcome after IVF is worse than in the
7. Moreno, Victor and others. Effect of Oral general population with similar maternal age, parity and social standing,
Contraceptives on Risk of Cervical Cancer mainly due to the large proportion of multiple births after IVF. The
in Women with Human Papilloma Virus In- higher prevalence of heart malformations does not solely arise from
fection: The IARC Multicentric Case-Control multiplicity but from other causes.
Study. Lancet, 2002;359:1085-92. 21. Weschler, Toni, Taking Charge of Your Fertility, Revised Edition, Quill,
8. Lidegaard, O. Oral contraceptives, pregnancy, 2001.
and the risk of cerebral thromboembolism: 22. Wynn V. Vitamins and oral contraceptive use. The Lancet, March 8,
the influence of diabetes, hypertension, mi- 1975.
graine and previous thrombotic disease. Br J 23. Langer, Stephen E, MD and James F Scheer. Solved: The Riddle of
Obstet Gynaecol 1995;102(2): 153-59. Illness. Keats Publishing, 2000.
9. Thorogood, M, J Mann and others. Is oral 24. Grant, E, MD. Sexual Chemistry: Understanding Our Hormones, the
contraceptive use still associated with an Pill and HRT. Cedar Press, 1994.
increased risk of fatal myocardial infarction? 25. Shannon, Marilyn M. Fertility, Cycles & Nutrition, 3rd Edition. Couple
Report of a case-control study. Br J Obstet to Couple League, 2001.
Gynaecol 1991;98:1245-1253.
10. Thorogood, M. and M Vessey. An epide-
miologic survey of cardiovascular disease
in women taking oral contraceptives. Am J

48 Wise Traditions